We are live on ! Find out more
TLSA icon

Tiziana Life Sciences

21 hedge funds and large institutions have $443K invested in Tiziana Life Sciences in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

0.01% more ownership

Funds ownership: 0.77%0.78% (+0.01%)

13% less funds holding

Funds holding: 2421 (-3)

15% less capital invested

Capital invested by funds: $522K → $443K (-$78.5K)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

Holders
21
Holders Change
-3
Holders Change %
-12.5%
% of All Funds
0.31%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
5
Reduced
2
Closed
6
Calls
$7K
Puts
Net Calls
+$7K
Net Calls Change
+$7K

TLSA Hedge Fund Activity: Q4 2023 in Review

21 of the 6,870 institutional investors tracked by Wall St. Rank reported a position in Tiziana Life Sciences (TLSA) for Q4 2023, worth a combined $443K — down 15% from $522K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of TLSA and 3 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 5 added.

The largest buyer was UBS Group, adding an estimated $17.6K. The largest seller was HSBC Holdings, cutting an estimated $12.6K.

  • 21 institutional investors held Tiziana Life Sciences (TLSA) as of Q4 2023, down from 24 in Q3 2023.
  • Funds reported $443K of Tiziana Life Sciences stock for Q4 2023, down 15% quarter-over-quarter.
  • 3 funds opened new Tiziana Life Sciences positions in Q4 2023 and 6 closed out, a net change of -3 holders.
  • The largest Tiziana Life Sciences buyer in Q4 2023 was UBS Group, an estimated $17.6K added.
  • The largest Tiziana Life Sciences seller in Q4 2023 was HSBC Holdings, an estimated $12.6K sold.

Based on aggregated 13F filings for Q4 2023.